Metabolic Syndrome and Leptin Level Associated With Fructose Consumption in Spain
Prevalence of Cardiovascular Risk Factors in Minorca - Spain
1 other identifier
observational
800
1 country
1
Brief Summary
A Food Frequency Questionnaire (FFQ), will be provided to 800 adults to assess overall fructose intake and this will be related to a number of features related to the metabolic syndrome, including serum leptin, characteristic features of metabolic syndrome (body mass index, waist circumference, plasma lipids, blood pressure, HOMA index,fasting glucose and fasting insulin levels) and other as: CRP, fibrinogen, homocysteine and uric acid.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jun 2008
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 28, 2008
CompletedFirst Posted
Study publicly available on registry
April 2, 2008
CompletedStudy Start
First participant enrolled
June 1, 2008
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2009
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2009
CompletedAugust 6, 2009
August 1, 2009
7 months
March 28, 2008
August 3, 2009
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Serum leptin levels as it relates to fructose intake
Epidemiological association
Secondary Outcomes (1)
Relationship of metabolic syndrome features with fructose intake. This includes measuring all 5 components of metabolic syndrome, assessing insulin resistance by HOMA, and measuring some markers of inflammation (CRP, fibrinogen, homocysteine)
Epidemiological
Eligibility Criteria
800 Adults, age 18 to 70
You may qualify if:
- Adults, 18-70 years of age
You may not qualify if:
- Diabetes
- Kidney Failure
- Heart Failure
- Cancer
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Renal Unit of Mateo Orfila Hospital, Balearic Islands - Spain
Menorca, Balearic Islands, 07703, Spain
Biospecimen
Serum and urine collections.
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- ECOLOGIC OR COMMUNITY
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
March 28, 2008
First Posted
April 2, 2008
Study Start
June 1, 2008
Primary Completion
January 1, 2009
Study Completion
June 1, 2009
Last Updated
August 6, 2009
Record last verified: 2009-08